Third, baseline data on PD-L1 expression and TMB were not collected; hence, whether PD-L1 expression and TMB could be predictive biomarkers for efficacy or prognosis in ES-SCLC is unknown. This evidence concerns the gene CD274 and small cell lung carcinoma.